Literature DB >> 82376

Serum haptoglobulin changes in patients with severe isolated head injury.

L Auer, W Petek.   

Abstract

From a series of 74 patients with severe head injuries and massive brain lesions, we measured the changes in haptoglobulin in 33 cases. On average, the globulin was, after a short drop in the first two days, increased about three times towards the seventh day, and was still above normal after ten days. Seen together with the total alpha-2-globulin increase after head injury this rise seems mainly to be caused by the haptoglobulin changes. Haptoglobulin was found to be a good indicator of the extent of brain tissue damage. It cannot on its own be used for prediction of survival chances.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 82376     DOI: 10.1007/BF01405338

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  16 in total

1.  SIMPLIFIED "DISC" (POLYACRYLAMIDE GEL) ELECTROPHORESIS.

Authors:  J T CLARKE
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  [On changes in the alpha 2 globulins of the serum].

Authors:  G SCHUMACHER; H D SCHLUMBERGER
Journal:  Dtsch Med Wochenschr       Date:  1963-03-29       Impact factor: 0.628

3.  [Properties, determination and clinical significance of haptoglobin].

Authors:  G SCHUMACHER; H D SCHLUMBERGER
Journal:  Klin Wochenschr       Date:  1962-01-15

4.  [Clinical and experimental studies on the behavior and function of alpha2-globulins. III. Haptoglobin changes in posttraumatic inflammations].

Authors:  G SCHUMACHER; H D SCHLUMBERGER
Journal:  Klin Wochenschr       Date:  1962-01-15

5.  Human haptoglobins: estimation and purification.

Authors:  G E CONNELL; O SMITHIES
Journal:  Biochem J       Date:  1959-05       Impact factor: 3.857

6.  [The Menkin factor, its related factors and their possible clinical significance].

Authors:  G SCHUMACHER
Journal:  Allerg Asthma (Leipz)       Date:  1957-12

7.  [Isolation in pure state of serum haptoglobin, mucoprotein alpha 2: properties and clinical significance].

Authors:  M F JAYLE; G BOUSSIER
Journal:  Presse Med       Date:  1954-12-18       Impact factor: 1.228

8.  Electrophoretic patterns of normal human serums by disc electrophoresis in polyscrylamide gel.

Authors:  J V Pastewka; A T Ness; A C Peacock
Journal:  Clin Chim Acta       Date:  1966-08       Impact factor: 3.786

9.  [Changes of serum proteins after craniocerebral trauma - comparison of alpha 2 and alpha 2M (author's transl)].

Authors:  L Auer; W Petek
Journal:  Acta Neurochir (Wien)       Date:  1976       Impact factor: 2.216

10.  Serum globulin changes in patients with craniocerebral trauma.

Authors:  L Auer; W Petek
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-11       Impact factor: 10.154

View more
  5 in total

1.  Proteolytic enzyme activity in patients with severe head injury and the effect of a proteinase inhibitor.

Authors:  L M Auer; E Marth; F Heppner; A Holasek
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

2.  Predicting lethal outcome after severe head injury -- a computer-assisted analysis of neurological symptoms and laboratory values.

Authors:  L M Auer; G Gell; B Richling; R Oberbauer; G Clarici; F Heppner
Journal:  Acta Neurochir (Wien)       Date:  1980       Impact factor: 2.216

Review 3.  Blood-Related Toxicity after Traumatic Brain Injury: Potential Targets for Neuroprotection.

Authors:  Steven A Robicsek; Ayon Bhattacharya; Ferenc Rabai; Krunal Shukla; Sylvain Doré
Journal:  Mol Neurobiol       Date:  2019-10-16       Impact factor: 5.682

4.  Age-Dependent Effects of Haptoglobin Deletion in Neurobehavioral and Anatomical Outcomes Following Traumatic Brain Injury.

Authors:  Alexander V Glushakov; Rodrigo A Arias; Emanuela Tolosano; Sylvain Doré
Journal:  Front Mol Biosci       Date:  2016-07-19

5.  Hypohaptoglobinemia associated with familial epilepsy.

Authors:  S S Panter; S M Sadrzadeh; P E Hallaway; J L Haines; V E Anderson; J W Eaton
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.